P53 IHCMDS

Alireza Rezvani1, Ahmad Monabati2, Zahra Kargar3

  • 1Department of Hematology, Medical Oncology and Stem Cell Transplantation, Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

PubMed
概括

通过评估p53表达,可以改善骨髓质疏松综合征 (MDS) 的预后. 这种免疫组织化学分析有助于预测MDS患者的生存率和指导治疗决策.